Filing Details

Accession Number:
0000899243-21-036500
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-17 21:48:07
Reporting Period:
2021-09-15
Accepted Time:
2021-09-17 21:48:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1656536 Decibel Therapeutics Inc. DBTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1492749 Laurence Reid C/O Decibel Therapeutics, Inc.
1325 Boylston Street, Suite 500
Boston MA 02215
President And Chief Executive Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-15 10,000 $7.64 25,849 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.587 to $7.65, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.